Face-to-Face: Drug Plan Management Forum Agenda
Wednesday December 1st 2010, Sutton Place Hotel
Theme: Drug Plan Management through Changing Times
7:30 - 8:30 a.m. |
Registration and Breakfast
|
8:30 - 8:40 a.m. |
Welcome and Opening Remarks
|
8:40 - 9:20 a.m. |
Drug Reform - The Next Chapter
A review of drug plan costs after drug reforms introduced in the past few months across Canada. What has happened to private drug plan costs?
Presenter:
Jamie Foley, Team Lead, Drug Plans, Economic Research, IMS Brogan
[DOWNLOAD THE PRESENTATION ]
|
9:20 - 10:00 a.m. |
Evaluating Drugs Apples vs Oranges?
Private drug plan formularies are challenged to find methods to compare similar drugs and establish their relative value. Value can be derived by assessing the benefit versus cost; however the value will vary significantly depending on what factors are included in the benefit and cost calculations. This session will explore the challenges, opportunities and best practices in evaluating efficacy and effectiveness when assessing drugs for private drug plan formularies.
Presenter:
Suzanne Lepage, Private Health Plan Strategist (This session made possible by Amgen)
[DOWNLOAD THE PRESENTATION ]
|
10:00 - 10:20 a.m. |
|
10:20 - 11:00 a.m. |
Emerging Approaches to Managing High Cost Drug Claimants
Managing the high cost of prescription drug claims is becoming an increasingly important issue for employers. As the prevalence of employees with tens of thousands of dollars in annual claims increases, employers are looking for ways to best balance the employee health needs and employer cost. Emerging approaches focus on better managing the employee's health and ongoing treatment, as well as ensuring the appropriate sources of payment (government, pharma manufacturer, COB) are co-ordinated. These initiatives seek to balance the sometimes conflicting objectives of maintaining benefit program sustainability and minimizing the financial burden on plan members. What are the new business models that the insurance industry is developing, and what do employers need to do to ensure this balance is met?
Presenter:
Tim Clarke, FSA FCIA National Health & Benefits Innovation Leader, Aon Hewitt Canadian Health & Benefits Consulting
[DOWNLOAD THE PRESENTATION ]
|
11:00 – 11:50 a.m. |
Expert Panel
Private drug plans play a significant role in the Canadian healthcare system and we all want them to remain sustainable in the years to come. We are fortunate to have representatives from many different sectors on this panel to provide insight and perspective on these issues.
Panelists:
John-Paul Dowson, Senior Manager, External Relations, Astra Zeneca
Paul Foley, Director Private Health Care, Shoppers Drug Mart
Frederic Lavoie , Director, Patient Access, Pfizer Canada
Leanne MacFarlane, Senior Director, Business Development, MHCSI
|
11:50 a.m. |
Closing Remarks and Conference Adjourns
|
For more information on this event, contact Catherine Lummack.
This page was last updated on November 30, 2010 |
|
